Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.

Whatever the consensus opinion may be, our team at StockStory cuts through the noise by conducting independent analysis to determine a company’s long-term prospects. Keeping that in mind, here is one stock where Wall Street’s pessimism is creating a buying opportunity and two where the outlook is warranted.

Two Stocks to Sell:

Skyworks Solutions (SWKS)

Consensus Price Target: $74.16 (0.2% implied return)

Result of a merger of Alpha Industries and the wireless communications division of Conexant, Skyworks Solutions (NASDAQ: SWKS) is a designer and manufacturer of chips used in smartphones, autos, and industrial applications to amplify, filter, and process wireless signals.

Why Do We Pass on SWKS?

1. Annual sales declines of 5.6% for the past two years show its products and services struggled to connect with the market during this cycle
2. Forecasted revenue decline of 1.6% for the upcoming 12 months implies demand will fall even further
3. Operating margin declined by 19 percentage points over the last five years as its sales cratered

Skyworks Solutions’s stock price of $74 implies a valuation ratio of 15.3x forward P/E. Check out our free in-depth research report to learn more about why SWKS doesn’t pass our bar.

Solventum (SOLV)

Consensus Price Target: $82.08 (8% implied return)

Founded in 1985, Solventum (NYSE: SOLV) develops, manufactures, and commercializes a portfolio of healthcare products and services addressing critical customer and therapeutic patient needs.

Why Do We Avoid SOLV?

1. Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy
2. Estimated sales for the next 12 months are flat and imply a softer demand environment
3. Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 30.8 percentage points

At $76 per share, Solventum trades at 11.3x forward P/E. Read our free research report to see why you should think twice about including SOLV in your portfolio.

One Stock to Watch:

W. R. Berkley (WRB)

Consensus Price Target: $67.38 (-0.1% implied return)

Founded in 1967 and operating through more than 50 specialized insurance units across the globe, W. R. Berkley (NYSE: WRB) underwrites commercial insurance and reinsurance through specialized subsidiaries serving industries from healthcare to construction to transportation.

Why Does WRB Catch Our Eye?

1. Strong 12.1% annualized net premiums earned expansion over the last five years shows it’s capturing market share this cycle
2. Performance over the past five years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
3. Capital generation for the next 12 months is expected to accelerate above its two-year trend as Wall Street forecasts robust book value per share growth of 24.3%

W. R. Berkley is trading at $67.46 per share, or 2.5x forward P/B. Is now the right time to buy? Find out in our full research report, it’s free.

Stocks We Like Even More

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.